Oregon Family Advocated for MLD Newborn Screening
The Floch family is pushing for state-mandated MLD testing to help identify the rare condition before symptoms develop.
Updated on Sept. 25, 2026 in Special Needs
After their daughter Corina was diagnosed with metachromatic leukodystrophy (MLD) in November 2025, the Floch family began advocating for mandatory newborn screening in Oregon. The federal government approved screening for the condition in December 2025, a change the family believes is vital for early intervention.
Why it matters
Newborn screening allows for the detection and treatment of MLD before symptoms fully develop, which is critical since therapies are most effective early on. The family seeks to prevent other children from experiencing the delayed diagnoses that impacted their own journey.
Active MLD occurs in 1 in 40,000 births, with 1 in 100 individuals carrying the recessive gene. Treatment efficacy is highly dependent on timing, and families are currently advocating at the state level to ensure consistent testing protocols.
The players
The Floch Family
A family advocating for state-level medical screening policy changes in Oregon.
Oregon Health & Science University
A Portland-based academic health center that coordinates long-term care for patients.
Children's Hospital of Philadelphia
A specialized pediatric facility that provides advanced care techniques for rare genetic diseases.
The details
MLD is a rare condition that requires specialized care, including speech-generating devices and surgically implanted gastrostomy tubes for nutrition. The Floch family coordinates this complex care through providers at Oregon Health & Science University and the Children's Hospital of Philadelphia. Treatments are most effective when administered prior to the onset of neurological symptoms.
Timeline
Corina Floch was born on May 19, 2023.
Corina was diagnosed with MLD in November 2025.
Federal government approved MLD screening in December 2025.
The family visited Philadelphia for specialized care in January 2026.
A Make-A-Wish trip to Florida is scheduled for December 2026.
The Home Front
The push for mandatory screening follows the recent federal approval of MLD testing protocols for newborns. This development marks a transition from reactive diagnosis toward systemic, proactive detection for rare genetic conditions.
Families managing chronic health conditions should maintain clear communication logs between all specialists, such as the teams at Oregon Health & Science University. Keep documentation of equipment, such as gastrostomy tube specifications, readily available to streamline care during travel.
The takeaway
Advocacy for broader newborn screening is a critical step in ensuring early detection for rare genetic conditions. Families affected by MLD can manage daily logistics by tracking feeding schedules, which for Corina involve 90-minute sessions three times a day.
Further reading
For more information on navigating resources for rare diagnoses, visit the Special Needs section.
Source note: This article includes information reported by NewsRegister.
